{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T17:02:22Z","timestamp":1768064542603,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006191","name":"Eski\u015fehir Osmangazi \u00dcniversitesi","doi-asserted-by":"publisher","award":["2017-11044"],"award-info":[{"award-number":["2017-11044"]}],"id":[{"id":"10.13039\/501100006191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s11255-019-02156-8","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T17:02:22Z","timestamp":1555952542000},"page":"1191-1197","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Correlation of serum galectin-3 level with renal volume and function in adult polycystic kidney disease"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7552-2186","authenticated-orcid":false,"given":"Sultan","family":"Ozkurt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oguzhan","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurdan","family":"Fidan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilter","family":"Bozaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behice","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muzaffer","family":"Bilgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"key":"2156_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/ndt\/gfu017","volume":"29","author":"EM Spithoven","year":"2014","unstructured":"Spithoven EM, Kramer A, Meijer E et al (2014) Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival\u2014an analysis of data from the ERA-EDTA registry. Nephrol Dial Transplant 29:15\u201325","journal-title":"Nephrol Dial Transplant"},{"key":"2156_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2215\/CJN.00330705","volume":"1","author":"JJ Grantham","year":"2006","unstructured":"Grantham JJ, Chapman AB, Torres VE (2006) Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin J Am Soc Nephrol 1:148\u2013157","journal-title":"Clin J Am Soc Nephrol"},{"key":"2156_CR3","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1681\/ASN.2012070650","volume":"24","author":"E Cornec-Le Gall","year":"2013","unstructured":"Cornec-Le Gall E, Audr\u00e9zet MP, Chen JM et al (2013) Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol 24:1006\u20131013","journal-title":"J Am Soc Nephrol"},{"key":"2156_CR4","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa054341","volume":"354","author":"JJ Grantham","year":"2006","unstructured":"Grantham JJ, Torres VE, Chapman AB et al (2006) Volume progression in polycystic kidney disease. N Engl J Med 354:2122\u20132130","journal-title":"N Engl J Med"},{"key":"2156_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2015.59","volume":"88","author":"AB Chapman","year":"2015","unstructured":"Chapman AB, Devuyst O, Eckardt KU et al (2015) Autosomal\u2014dominant polycystic kidney disease (ADPKD): executive summary from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int 88:17\u201327","journal-title":"Kidney Int"},{"key":"2156_CR6","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O et al (2012) Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367:2407\u20132418","journal-title":"N Engl J Med"},{"key":"2156_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000491022","volume":"48","author":"R Magistroni","year":"2018","unstructured":"Magistroni R, Corsi C, Mart\u00ed T, Torra R (2018) A review of the imaging techniques for measuring kidney and cyst volume in establishing autosomal dominant polycystic kidney disease progression. Am J Nephrol 48:67\u201378","journal-title":"Am J Nephrol"},{"key":"2156_CR8","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","volume":"64","author":"AB Chapman","year":"2003","unstructured":"Chapman AB, Guay-Woodford LM, Grantham JJ et al (2003) Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): the consortium for radiologic imaging studies of polycystic kidney disease (CRISP) cohort. Kidney Int 64:1035\u20131045","journal-title":"Kidney Int"},{"key":"2156_CR9","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00467-014-2882-8","volume":"30","author":"JJ Grantham","year":"2015","unstructured":"Grantham JJ (2015) Rationale for early treatment of polycystic kidney disease. Pediatr Nephrol 30:1053\u20131062","journal-title":"Pediatr Nephrol"},{"key":"2156_CR10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nrneph.2011.109","volume":"7","author":"JJ Grantham","year":"2011","unstructured":"Grantham JJ, Mulamalla S, Swenson-Fields KI (2011) Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 7:556\u2013566","journal-title":"Nat Rev Nephrol"},{"key":"2156_CR11","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.autrev.2008.11.009","volume":"8","author":"A Dhirapong","year":"2009","unstructured":"Dhirapong A, Lleo A, Leung P, Gershwin ME, Liu FT (2009) The immunological potential of galectin-1 and -3. Autoimmun Rev 8:360\u2013363","journal-title":"Autoimmun Rev"},{"key":"2156_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1600-065X.2009.00794.x","volume":"203","author":"NC Henderson","year":"2009","unstructured":"Henderson NC, Sethi T (2009) The regulation of inflammation by galectin-3. Immunol Rev 203:160\u2013171","journal-title":"Immunol Rev"},{"issue":"9","key":"2156_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612","journal-title":"Ann Intern Med"},{"key":"2156_CR14","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","volume":"110","author":"UC Sharma","year":"2004","unstructured":"Sharma UC, Pokharel S, van Brakel TJ et al (2004) Galectin-3 marks activated macrophages in failure prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 110:3121\u20133128","journal-title":"Circulation"},{"key":"2156_CR15","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/eurjhf\/hfp097","volume":"11","author":"RA Boer de","year":"2009","unstructured":"de Boer RA, Voors AA, Muntendam P, van Gilst WH, van Veldhuisen DJ (2009) Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail 11:811\u2013817","journal-title":"Eur J Heart Fail"},{"key":"2156_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00392-010-0125-y","volume":"99","author":"DJ Lok","year":"2010","unstructured":"Lok DJ, Van Der Meer P, de la Porte PW et al (2010) Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure. Clin Res Cardiol 99:323\u2013328","journal-title":"Clin Res Cardiol"},{"key":"2156_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cca.2009.09.001","volume":"409","author":"YH Lin","year":"2009","unstructured":"Lin YH, Lin LY, Wu YW et al (2009) The relationship between serum galectin-3 and serum markers of cardiac extracellular matrix turnover in heart failure patients. Clin Chim Acta 409:96\u201399","journal-title":"Clin Chim Acta"},{"key":"2156_CR18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3909\/ricm0624","volume":"12","author":"PA McCullough","year":"2011","unstructured":"McCullough PA, Olobatoke A, Vanhecke TE (2011) Galectin-3: a novel blood test for the evaluation and management of patients with heart failure. Rev Cardiovasc Med 12:200\u2013210","journal-title":"Rev Cardiovasc Med"},{"key":"2156_CR19","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jchf.2016.06.010","volume":"4","author":"A Grupper","year":"2016","unstructured":"Grupper A, Nativi-Nicolau J, Maleszewski JJ et al (2016) Circulating galectin-3 levels are persistently elevated after heart transplantation and are associated with renal dysfunction. JACC Heart Fail 4:847\u2013856","journal-title":"JACC Heart Fail"},{"key":"2156_CR20","doi-asserted-by":"publisher","first-page":"e000962","DOI":"10.1161\/JAHA.114.000962","volume":"3","author":"WC Meijers","year":"2014","unstructured":"Meijers WC, van der Velde AR, Ruifrok WP et al (2014) Renal handling of galectin-3 in the general population, chronic heart failure, and hemodialysis. J Am Heart Assoc 3:e000962","journal-title":"J Am Heart Assoc"},{"key":"2156_CR21","doi-asserted-by":"publisher","first-page":"e000760","DOI":"10.1161\/JAHA.112.000760","volume":"1","author":"DM Gopal","year":"2012","unstructured":"Gopal DM, Kommineni M, Ayalon N et al (2012) Relationship of plasma galectin-3 to renal function in patients with heart failure: effects of clinical status, pathophysiology of heart failure, and presence or absence of heart failure. J Am Heart Assoc 1:e000760","journal-title":"J Am Heart Assoc"},{"key":"2156_CR22","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1681\/ASN.2013010019","volume":"24","author":"CM O\u2019Seaghdha","year":"2013","unstructured":"O\u2019Seaghdha CM, Hwang SJ, Ho JE, Vasan RS, Levy D, Fox CS (2013) Elevated galectin-3 precedes the development of CKD. J Am Soc Nephrol 24:1880\u20131888","journal-title":"J Am Soc Nephrol"},{"key":"2156_CR23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1681\/ASN.V123515","volume":"12","author":"SL Bullock","year":"2001","unstructured":"Bullock SL, Johnson TM, Bao Q, Hughes RC, Winyard PJ, Woolf AS (2001) Galectin-3 modulates ureteric bud branching in organ culture of the developing mouse kidney. J Am Soc Nephrol 12:515\u2013523","journal-title":"J Am Soc Nephrol"},{"key":"2156_CR24","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1083\/jcb.151.6.1235","volume":"151","author":"C Hikita","year":"2000","unstructured":"Hikita C, Vijayakumar S, Takito J, Erdjument- Bromage H, Tempst P, Al-Awqati Q (2000) Induction of terminal differentiation in epithelial cells requires polymerization of hensin by galectin 3. J Cell Biol 151:1235\u20131246","journal-title":"J Cell Biol"},{"key":"2156_CR25","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1542\/peds.111.5.1072","volume":"111","author":"LM Guay-Woodford","year":"2003","unstructured":"Guay-Woodford LM, Desmond RA (2003) Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics 111:1072\u20131080","journal-title":"Pediatrics"},{"key":"2156_CR26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/glycob\/9.5.489","volume":"9","author":"Q Bao","year":"1999","unstructured":"Bao Q, Hughes RC (1999) Galectin-3 and polarized growth within collagen gels of wild-type and ricin-resistant MDCK renal epithelial cells. Glycobiology 9:489\u2013495","journal-title":"Glycobiology"},{"issue":"315","key":"2156_CR27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1152\/ajprenal.00346.2017","volume":"1","author":"EE Olsan","year":"2018","unstructured":"Olsan EE, West JD, Torres JA, Doerr N, Weimbs T (2018) Identification of targets of IL-13 and STAT6 signaling in polycystic kidney disease. Am J Physiol Renal Physiol 1(315):86\u201396","journal-title":"Am J Physiol Renal Physiol"},{"key":"2156_CR28","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1111\/j.1432-2277.2008.00705.x","volume":"21","author":"AP Fernandes Bertocchi","year":"2018","unstructured":"Fernandes Bertocchi AP, Campanhole G, Wang PH et al (2018) A role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury. Transpl Int 21:999\u20131007","journal-title":"Transpl Int"},{"key":"2156_CR29","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0002-9440(10)64595-6","volume":"157","author":"J Nishiyama","year":"2000","unstructured":"Nishiyama J, Kobayashi S, Ishida A et al (2000) Up-regulation of galectin-3 in acute renal failure of the rat. Am J Pathol 157:815\u2013823","journal-title":"Am J Pathol"},{"key":"2156_CR30","first-page":"1417","volume":"25","author":"D Vansthertem","year":"2010","unstructured":"Vansthertem D, Cludts S, Nonclercq D et al (2010) Immunohistochemical localization of galectins-1 and -3 and monitoring of tissue galectin-binding sites during tubular regeneration after renal ischemia reperfusion in the rat. Histol Histopathol 25:1417\u20131429","journal-title":"Histol Histopathol"},{"key":"2156_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/ajprenal.00326.2010","volume":"300","author":"DM Okamura","year":"2010","unstructured":"Okamura DM, Pasichnyk K, Lopez-Guisa JM et al (2010) Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis. Am J Physiol Renal Physiol 300:245\u2013253","journal-title":"Am J Physiol Renal Physiol"},{"key":"2156_CR32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/0961203308094361","volume":"18","author":"EH Kang","year":"2009","unstructured":"Kang EH, Moon KC, Lee EY et al (2009) Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritis. Lupus 18:22\u201328","journal-title":"Lupus"},{"key":"2156_CR33","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/S0140-6736(99)90069-7","volume":"353","author":"DL Mann","year":"1999","unstructured":"Mann DL (1999) Inflammatory mediators in heart failure: homogeneity through heterogeneity. Lancet 353:1812\u20131813","journal-title":"Lancet"},{"key":"2156_CR34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5858\/2008-0392-OAR1.1","volume":"134","author":"JY Dancer","year":"2010","unstructured":"Dancer JY, Truong LD, Zhai Q, Shen SS (2010) Expression of galectin-3 in renal neoplasms: a diagnostic, possible prognostic marker. Arch Pathol Lab Med 134:90\u201394","journal-title":"Arch Pathol Lab Med"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-019-02156-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-019-02156-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-019-02156-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T14:29:26Z","timestamp":1663338566000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-019-02156-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2156"],"URL":"https:\/\/doi.org\/10.1007\/s11255-019-02156-8","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"29 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no declared conflicts of interest in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}